Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer. / Nielsen, Signe Smith; He, Yulei; Ayanian, John Z.; Gomez, Scarlett Lin; Kahn, Katherine L.; West, Dee W.; Keating, Nancy L.

In: Cancer, Vol. 116, 2010, p. 5497-506.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nielsen, SS, He, Y, Ayanian, JZ, Gomez, SL, Kahn, KL, West, DW & Keating, NL 2010, 'Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer', Cancer, vol. 116, pp. 5497-506.

APA

Nielsen, S. S., He, Y., Ayanian, J. Z., Gomez, S. L., Kahn, K. L., West, D. W., & Keating, N. L. (2010). Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer. Cancer, 116, 5497-506.

Vancouver

Nielsen SS, He Y, Ayanian JZ, Gomez SL, Kahn KL, West DW et al. Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer. Cancer. 2010;116:5497-506.

Author

Nielsen, Signe Smith ; He, Yulei ; Ayanian, John Z. ; Gomez, Scarlett Lin ; Kahn, Katherine L. ; West, Dee W. ; Keating, Nancy L. / Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer. In: Cancer. 2010 ; Vol. 116. pp. 5497-506.

Bibtex

@article{0478f4f09e3711df928f000ea68e967b,
title = "Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer",
abstract = " BACKGROUND: Disparities in care have been documented for foreign-born cancer patients in the United States. However, few data are available regarding patients with lung and colorectal cancer. In the current study, the authors assessed whether patient-reported quality and receipt of recommended care differed between US-born and foreign-born cancer patients. METHODS: The authors collected surveys and medical records for a population-based cohortincluding white, Hispanic, and Asian adults (2205 US-born and 890 foreign-born individuals) with lung or colorectal cancer diagnosed in California from 2003 through 2005. Logistic regression was used to assess the association between nativity and patient-reported quality of care and receipt of recommended treatments (adjuvant chemotherapy for stage III colon cancer, adjuvant chemotherapy and radiotherapy for stage II/III rectal cancer, and curative surgery for stage I/II non-small cell lung cancer). The authors also assessed whether language explained any differences in care by nativity. RESULTS: Overall, 46% of patients reported excellent care, but foreign-born patients were less likely than US-born patients to report excellent quality of care (adjusted odds ratio [AOR], 0.80; 95% confidence interval [95% CI], 0.65-1.00), a difference partly explained by the language of the survey, an indicator of English proficiency. Rates of recommended therapies ranged from 64% to 85%; foreign-born patients were less likely to receive chemotherapy and radiotherapy for stage II/III rectal cancer (AOR, 0.35; 95% CI, 0.12-0.99). Rates of other treatments did not differ significantly by nativity. CONCLUSIONS: Foreign-born cancer patients reported lower quality of care and were less likely to receive some cancer therapies than patients born in the Unites States. Better coordination of care and communication regarding cancer treatments and expanded use of interpreters may lessen these disparities.",
keywords = "Faculty of Health and Medical Sciences, Cancer, immigrants, Ethnicity, asian, White, hispanics, quality of care, Quality, USA, receipt of treatment, inequalities",
author = "Nielsen, {Signe Smith} and Yulei He and Ayanian, {John Z.} and Gomez, {Scarlett Lin} and Kahn, {Katherine L.} and West, {Dee W.} and Keating, {Nancy L.}",
year = "2010",
language = "English",
volume = "116",
pages = "5497--506",
journal = "Cancer",
issn = "0008-543X",
publisher = "JohnWiley & Sons, Inc.",

}

RIS

TY - JOUR

T1 - Quality of Cancer Care Among Foreign-Born and US-Born Patients With Lung or Colorectal Cancer

AU - Nielsen, Signe Smith

AU - He, Yulei

AU - Ayanian, John Z.

AU - Gomez, Scarlett Lin

AU - Kahn, Katherine L.

AU - West, Dee W.

AU - Keating, Nancy L.

PY - 2010

Y1 - 2010

N2 -  BACKGROUND: Disparities in care have been documented for foreign-born cancer patients in the United States. However, few data are available regarding patients with lung and colorectal cancer. In the current study, the authors assessed whether patient-reported quality and receipt of recommended care differed between US-born and foreign-born cancer patients. METHODS: The authors collected surveys and medical records for a population-based cohortincluding white, Hispanic, and Asian adults (2205 US-born and 890 foreign-born individuals) with lung or colorectal cancer diagnosed in California from 2003 through 2005. Logistic regression was used to assess the association between nativity and patient-reported quality of care and receipt of recommended treatments (adjuvant chemotherapy for stage III colon cancer, adjuvant chemotherapy and radiotherapy for stage II/III rectal cancer, and curative surgery for stage I/II non-small cell lung cancer). The authors also assessed whether language explained any differences in care by nativity. RESULTS: Overall, 46% of patients reported excellent care, but foreign-born patients were less likely than US-born patients to report excellent quality of care (adjusted odds ratio [AOR], 0.80; 95% confidence interval [95% CI], 0.65-1.00), a difference partly explained by the language of the survey, an indicator of English proficiency. Rates of recommended therapies ranged from 64% to 85%; foreign-born patients were less likely to receive chemotherapy and radiotherapy for stage II/III rectal cancer (AOR, 0.35; 95% CI, 0.12-0.99). Rates of other treatments did not differ significantly by nativity. CONCLUSIONS: Foreign-born cancer patients reported lower quality of care and were less likely to receive some cancer therapies than patients born in the Unites States. Better coordination of care and communication regarding cancer treatments and expanded use of interpreters may lessen these disparities.

AB -  BACKGROUND: Disparities in care have been documented for foreign-born cancer patients in the United States. However, few data are available regarding patients with lung and colorectal cancer. In the current study, the authors assessed whether patient-reported quality and receipt of recommended care differed between US-born and foreign-born cancer patients. METHODS: The authors collected surveys and medical records for a population-based cohortincluding white, Hispanic, and Asian adults (2205 US-born and 890 foreign-born individuals) with lung or colorectal cancer diagnosed in California from 2003 through 2005. Logistic regression was used to assess the association between nativity and patient-reported quality of care and receipt of recommended treatments (adjuvant chemotherapy for stage III colon cancer, adjuvant chemotherapy and radiotherapy for stage II/III rectal cancer, and curative surgery for stage I/II non-small cell lung cancer). The authors also assessed whether language explained any differences in care by nativity. RESULTS: Overall, 46% of patients reported excellent care, but foreign-born patients were less likely than US-born patients to report excellent quality of care (adjusted odds ratio [AOR], 0.80; 95% confidence interval [95% CI], 0.65-1.00), a difference partly explained by the language of the survey, an indicator of English proficiency. Rates of recommended therapies ranged from 64% to 85%; foreign-born patients were less likely to receive chemotherapy and radiotherapy for stage II/III rectal cancer (AOR, 0.35; 95% CI, 0.12-0.99). Rates of other treatments did not differ significantly by nativity. CONCLUSIONS: Foreign-born cancer patients reported lower quality of care and were less likely to receive some cancer therapies than patients born in the Unites States. Better coordination of care and communication regarding cancer treatments and expanded use of interpreters may lessen these disparities.

KW - Faculty of Health and Medical Sciences

KW - Cancer

KW - immigrants

KW - Ethnicity

KW - asian

KW - White

KW - hispanics

KW - quality of care

KW - Quality

KW - USA

KW - receipt of treatment

KW - inequalities

M3 - Journal article

VL - 116

SP - 5497

EP - 5506

JO - Cancer

JF - Cancer

SN - 0008-543X

ER -

ID: 21138579